skip to main content
Idioma:
Refinado por: assunto: Biological And Medical Sciences remover assunto: Treatment Outcome remover Female remover Double-Blind Method remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial

Vincent, Jean-Louis ; Angus, Derek C ; Artigas, Antonio ; Kalil, Andre ; Basson, Bruce R ; Jamal, Hassan H ; Johnson, Gerald ; Bernard, Gordon R

Critical care medicine, 2003-03, Vol.31 (3), p.834-840 [Periódico revisado por pares]

Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
2
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Steigbigel, Roy T ; Cooper, David A ; Kumar, Princy N ; Eron, Joseph E ; Schechter, Mauro ; Markowitz, Martin ; Loutfy, Mona R ; Lennox, Jeffrey L ; Gatell, Jose M ; Rockstroh, Jurgen K ; Katlama, Christine ; Yeni, Patrick ; Lazzarin, Adriano ; Clotet, Bonaventura ; Zhao, Jing ; Chen, Joshua ; Ryan, Desmond M ; Rhodes, Rand R ; Killar, John A ; Gilde, Lucinda R ; Strohmaier, Kim M ; Meibohm, Anne R ; Miller, Michael D ; Hazuda, Daria J ; Nessly, Michael L ; DiNubile, Mark J ; Isaacs, Robin D ; Nguyen, Bach-Yen ; Teppler, Hedy

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Cooper, David A ; Steigbigel, Roy T ; Gatell, Jose M ; Rockstroh, Jurgen K ; Katlama, Christine ; Yeni, Patrick ; Lazzarin, Adriano ; Clotet, Bonaventura ; Kumar, Princy N ; Eron, Joseph E ; Schechter, Mauro ; Markowitz, Martin ; Loutfy, Mona R ; Lennox, Jeffrey L ; Zhao, Jing ; Chen, Joshua ; Ryan, Desmond M ; Rhodes, Rand R ; Killar, John A ; Gilde, Lucinda R ; Strohmaier, Kim M ; Meibohm, Anne R ; Miller, Michael D ; Hazuda, Daria J ; Nessly, Michael L ; DiNubile, Mark J ; Isaacs, Robin D ; Teppler, Hedy ; Nguyen, Bach-Yen

The New England journal of medicine, 2008-07, Vol.359 (4), p.355-365 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Eron, Joseph J, Prof ; Cooper, David A, Prof ; Steigbigel, Roy T, Prof ; Clotet, Bonaventura, MD ; Gatell, Jose M, Prof ; Kumar, Princy N, Prof ; Rockstroh, Jurgen K, Prof ; Schechter, Mauro, Prof ; Markowitz, Martin, Prof ; Yeni, Patrick, MD ; Loutfy, Mona R, MD ; Lazzarin, Adriano, Prof ; Lennox, Jeffrey L, Prof ; Strohmaier, Kim M, BS ; Wan, Hong, MS ; Barnard, Richard JO, PhD ; Nguyen, Bach-Yen T, MD ; Teppler, Hedy, MD

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial

DHAINAUT, Jean-Francois ; LATERRE, Pierre-Francois ; VINCENT, Jean-Louis ; JANES, Jonathan M ; BERNARD, Gordon R ; ARTIGAS, Antonio ; BAKKER, Jan ; RIESS, Hanno ; BASSON, Bruce R ; CHARPENTIER, Julien ; UTTERBACK, Barbara G

Intensive care medicine, 2003-06, Vol.29 (6), p.894-903 [Periódico revisado por pares]

Heidelberg: Springer

Texto completo disponível

Citações Citado por
6
Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia

VALLES, J ; ARTIGAS, A ; RELLO, J ; BONSOMS, N ; FONTANALS, D ; BLANCH, L ; FERNANDEZ, R ; BAIGORRI, F ; MESTRE, J

Annals of internal medicine, 1995-02, Vol.122 (3), p.179-186 [Periódico revisado por pares]

Philadelphia, PA: American College of Physicians

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.